3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow PharmaEngine: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid Tumors Nanoliposomal Irinotecan - Refractory Solid Tumors | Phase 1 | Completed | PharmaEngine | 44 | 2019-03-05 | 2023-11-18 |
| Phase I and Pharmacokinetic Study of Biweekly PEP02 in mCRC Refractory to 1st-line Oxaliplatin Base Therapy PEP02 - Metastatic Colorectal Cancer | Phase 1 | Completed | PharmaEngine | 18 | 2009-06-01 | 2017-04-06 |
| A Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Tumors PEP02, 5-FU, LV - Solid Tumor | Phase 1 | Completed | PharmaEngine | 16 | 2006-01-01 | 2016-08-30 |
irinotecan sucrosofate (2) · Fluorouracil (1) · Leucovorin (1) · trifluridine tipiracil drug combination (1)
Taiwan (2)
Chia-Chi Lin, MD (1)